宣传 发表于 2025-3-28 14:50:14

http://reply.papertrans.cn/20/1906/190593/190593_41.png

江湖郎中 发表于 2025-3-28 22:12:04

http://reply.papertrans.cn/20/1906/190593/190593_42.png

祸害隐伏 发表于 2025-3-29 00:24:45

http://reply.papertrans.cn/20/1906/190593/190593_43.png

疼死我了 发表于 2025-3-29 06:04:53

http://reply.papertrans.cn/20/1906/190593/190593_44.png

AMPLE 发表于 2025-3-29 10:04:08

http://reply.papertrans.cn/20/1906/190593/190593_45.png

Infraction 发表于 2025-3-29 15:11:14

Neoadjuvant Hormonal Therapy in Breast Cancernt of locally advanced breast cancer, there are two options: chemotherapy or hormonal therapy. Chemotherapy can be toxic for postmenopausal elderly patients, and neoadjuvant hormonal therapy is an option for hormone receptor-positive locally advanced postmenopausal breast cancer. Such a treatment is

中子 发表于 2025-3-29 19:13:15

http://reply.papertrans.cn/20/1906/190593/190593_47.png

不能逃避 发表于 2025-3-29 23:07:15

http://reply.papertrans.cn/20/1906/190593/190593_48.png

BRINK 发表于 2025-3-30 01:13:26

Pingyue Zhang,Mengyue Wu,Kai Yu benign lesions or when coring biopsy tools fail to provide adequate diagnostic information and material. Ductoscopy, which was initially developed as a tool to investigate pathological nipple discharge, is an evolving technology that may have an increasing role in research and prevention, as tools

AVOID 发表于 2025-3-30 06:11:47

Man-Machine Speech Communicationne prognostic signature or Oncotype DX tests may provide additional prognostic and predictive information beyond anatomic TNM staging and the estrogen receptor/progesterone receptor (ER/PR) and human epidermal growth factor receptor-2 (HER-2) status. In 2017, the eighth revised edition of the TNM sy
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Breast Disease; Management and Thera Adnan Aydiner,Abdullah Igci,Atilla Soran Book 2019Latest edition Springer Nature Switzerland AG 2019 b